CMO Dr. Andrew Hertler on the Recent FDA ODAC Meeting
New Century Health, a national leader in specialty care management, is proud to provide comprehensive oncol...
Evidence-Based Oncology interviews our CMO about mismatches between drug costs and efficacy.
Our CMO speaks with Managed Care Executive about the promise and perils of genomic testing.
Modern Healthcare spoke with NCH's Dr. Andrew Hertler about problems in the FDA's approval process.
Our CMO speaks with Formulary Watch about the challenges of high--cost drugs with marginal benefit.
The FDA's Aduhelm approval was highly controversial, but not as surprising for those who follow the oncology drug pipeline.
New Century Health, a national leader in specialty care management, is proud to provide comprehensive oncology specialty management services to Neighborhood Health Plan of Rhode Island.
Our CMO Dr. Andrew Hertler speaks with HFMA about the role of telehealth in oncology care today.
From cytotoxic chemotherapy to targeted therapy: we’ve entered a new era of cancer care. What is life like as a provider in this new era? How can oncologists keep up with the latest science?
Palliative care—supportive care—is a glaring need in cancer care, but myths, misconceptions and mixed messages create barriers for broader palliative program implementation.
There is tremendous excitement around the concept of precision oncology. But how many patients will truly benefit from these treatments? And do the results for these patients justify the hype?
In this podcast series we explore the trends and forces behind the two leading causes of death in the United States: cancer and heart disease.
New Century Health announced that 2020 was the largest membership growth year in the 19-year history of the company.
Payer strains now top the list of stressors facing oncologists, with prior authorization as the most-cited source of that payer stress.
NCH's approach to more appropriate use of myeloid growth factor provides a playbook for how to change prescribing patterns.
New Century Health recently convened health plan executives, industry experts and oncologists from across the nation to discuss the confluence of forces shaping oncology care in 2021 and beyond.
The company will leverage New Century Health’s oncology specialty management program to help ensure its more than 125,000 Medicare Advantage members receive high-quality cancer care.
New Century Health’s John Davis hosts a virtual “fireside chat” with Dr. Elizabeth Malko, Dr. Vinay Prasad, and Dr. Andrew Hertler.
Our CMO Dr. Andrew Hertler explains how real world evidence may usher in the next generation of clinical oncology pathways.
Recent journal article details how NCH and Cancer Care Specialists of Illinois teamed up to slow growth in drug spend.